Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Pirro

Showing results (11-20 of 265) with videos related to

Pageof 27
Sort By:
Hypertension (Dallas, Tex. : 1979)|September 26, 2007
Left ventricular hypertrophy reversal and prevention of diabetes: two birds with one stone?Giuseppe Schillaci, Matteo Pirro, Elmo Mannarino
The New England Journal of Medicine|November 17, 2017
Cognitive Function in a Randomized Trial of EvolocumabPaolo Calabrò, Felice Gragnano, Matteo Pirro
JAMA Cardiology|December 1, 2017
Simulation Models of Therapy Intensification in Lipid-Lowering Medicine: Fact or Fantasy?Paolo Calabrò, Felice Gragnano, Matteo Pirro
Trends in Cardiovascular Medicine|March 25, 2020
Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levelsVanessa Bianconi, Maciej Banach, Matteo Pirro, et al.
Circulation|February 28, 2002
Serum triglyceride concentration and coronary heart diseaseGiuseppe Schillaci, Matteo Pirro, Elmo Mannarino
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 9, 2009
The emerging role of atherosclerotic cardiovascular disease in systemic lupus erythematosusGiuseppe Schillaci, Giacomo Pucci, Matteo Pirro
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|May 9, 2019
Commentary to "The Possible Role of Nutraceuticals in the Prevention of Cardiovascular Disease"Massimo R Mannarino, Vanessa Bianconi, Matteo Pirro
European Journal of Preventive Cardiology|January 10, 2020
Editorial: 'Tea consumption and the risk of atherosclerotic cardiovascular disease and all-cause mortality: The China-PAR project'Vanessa Bianconi, Massimo R Mannarino, Matteo Pirro
BMC Medicine|October 9, 2020
LDL-C: lower is better for longer-even at low riskPeter E Penson, Matteo Pirro, Maciej Banach
Cardiovascular Drugs and Therapy|September 6, 2005
Treating hypertensive non-dippers: additional benefit from nocturnal blood pressure reduction?Giuseppe Schillaci, Massimo R Mannarino, Matteo Pirro
Pageof 27

Showing results (11-20 of 265) with videos related to

Sort By:
Pageof 27
Hypertension (Dallas, Tex. : 1979)|September 26, 2007
Left ventricular hypertrophy reversal and prevention of diabetes: two birds with one stone?Giuseppe Schillaci, Matteo Pirro, Elmo Mannarino
The New England Journal of Medicine|November 17, 2017
Cognitive Function in a Randomized Trial of EvolocumabPaolo Calabrò, Felice Gragnano, Matteo Pirro
JAMA Cardiology|December 1, 2017
Simulation Models of Therapy Intensification in Lipid-Lowering Medicine: Fact or Fantasy?Paolo Calabrò, Felice Gragnano, Matteo Pirro
Trends in Cardiovascular Medicine|March 25, 2020
Why patients with familial hypercholesterolemia are at high cardiovascular risk? Beyond LDL-C levelsVanessa Bianconi, Maciej Banach, Matteo Pirro, et al.
Circulation|February 28, 2002
Serum triglyceride concentration and coronary heart diseaseGiuseppe Schillaci, Matteo Pirro, Elmo Mannarino
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 9, 2009
The emerging role of atherosclerotic cardiovascular disease in systemic lupus erythematosusGiuseppe Schillaci, Giacomo Pucci, Matteo Pirro
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|May 9, 2019
Commentary to "The Possible Role of Nutraceuticals in the Prevention of Cardiovascular Disease"Massimo R Mannarino, Vanessa Bianconi, Matteo Pirro
European Journal of Preventive Cardiology|January 10, 2020
Editorial: 'Tea consumption and the risk of atherosclerotic cardiovascular disease and all-cause mortality: The China-PAR project'Vanessa Bianconi, Massimo R Mannarino, Matteo Pirro
BMC Medicine|October 9, 2020
LDL-C: lower is better for longer-even at low riskPeter E Penson, Matteo Pirro, Maciej Banach
Cardiovascular Drugs and Therapy|September 6, 2005
Treating hypertensive non-dippers: additional benefit from nocturnal blood pressure reduction?Giuseppe Schillaci, Massimo R Mannarino, Matteo Pirro
Pageof 27